Home  >  Products  >  CCDC99 (coiled-coil domain containing 99 ) Blocking Peptide (the C terminal of CCDC99)(100ug)
CCDC99 (coiled-coil domain containing 99 ) Blocking Peptide (the C terminal of CCDC99)(100ug)

CCDC99 (coiled-coil domain containing 99 ) Blocking Peptide (the C terminal of CCDC99)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-CCDC99 Antibody (ARP67438_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP67438
Size: 100ug
Weight: 67kDa
Gene: 54908
Format: Lyophilized powder
Target: CCDC99 is required for the localization of dynein and dynactin to the mitotic kintochore. Dynein is believed to control the initial lateral interaction between the kinetochore and spindle microtubules and to facilitate the subsequent formation of end-on kinetochore-microtubule attachments mediated by the NDC80 complex. CCDC99 is also required for correct spindle orientation. It does not appear to be required for the removal of spindle assembly checkpoint (SAC) proteins from the kinetochore upon bipolar spindle attachment.
Alternative names: FLJ20364; FLJ40690